Browsing by Author "Calleja, J.L."
Now showing items 1-4 of 4
-
Deep-Sequencing Reveals Broad Subtype-Specific HCV Resistance Mutations Associated with Treatment Failure
Chen, Qian; Perales, Celia; Soria, María Eugenia; García-Cehic, Damir; Gregori, Josep; Rodríguez-Frías, Francisco; Buti, M.; Crespo, Javier; Calleja, J.L.; Tabernero, David; Vila Salvador, Marta; Lázaro, Fernando; Rando-Segura, Ariadna; Nieto-Aponte, Leonardo; Llorens-Revull, Meritxell; Cortese, Maria Francesca; Fernández, Irati; Castellote, José; Niubó, Jordi; Imaz, Arkaitz; Delgado, Manuel; Cañizares, Angelina; Castro-Iglesias, Ángeles (Elsevier, 2019-12-16)[Abstract] A percentage of hepatitis C virus (HCV)-infected patients fail direct acting antiviral (DAA)-based treatment regimens, often because of drug resistance-associated substitutions (RAS). The aim of this study was ... -
Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice
Cabezas, Joaquín; Londoño, M.C.; Llerena, S.; Muñoz, R.; Baliellas, C.; Buti, M.; Pascasio, J.M.; Sáez-Royuela, F.; García-Samaniego, J.; Vega, J. de la; Sánchez-Pobre, P.; Álvarez-Navascues, C.; Carrión, J.A.; Gea, F.; Morillas, R.M.; Fernández-Bermejo, M.; Castro-Iglesias, Ángeles; Rivero, M.; Fernández, J.R.; Berenguer, M.; Moreno, J.J.; Rincón, D.; Calleja, J.L.; Crespo, J. (Elsevier, 2016) -
Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4
Mariño, Zoe; Pascasio-Acevedo, Juan M.; Sánchez-Antolín, Gloria; Baliellas, C.; Prieto, M.; Moreno, J.M.; Carrión, J.A.; Fernández, I.; Gómez, A.; Montero, J.L.; Castro-Iglesias, Ángeles; Pascual, Sonia; Cabezas, Joaquín; Arencibia, Ana C.; Calleja, J.L.; Sánchez Ruano, Juan José; Castells, Lluis; Albillos, A.; Romero-Gómez, Manuel; García-Samaniego, J.; Narváez, Isidro; Serrano, T.; Giráldez, Álvaro; Xiol, X.; Hontagas, V.; Cuervas-Mons Martínez, Valentín; Crespo, J.; Forns, Xavier (Elsevier, 2016) -
Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort
Riveiro-Barciela, M.; Alonso, Sonia; Fernández, Inmaculada; Rincón, Diego; Real, Yolanda; Crespo, Javier; Gea, Francisco; Olveira, Antonio; Calleja, J.L.; Polo-Lorduy, B.; Carrión, J.A.; Arenas, J.; Devesa, M.J.; Baliellas, C.; Castro-Iglesias, Ángeles; Romero-Gómez, Manuel; Granados, R.; Pascasio, J.M.; Forns, Xavier; Turnes, Juan; Montero, J.L.; Esteban, R.; Fernández-Rodríguez, Conrado M. (Wiley, 2016-10)